Table 5.
Variables | Models | ||||||
---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | |||||
Age group | Quartiles | OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value |
Dynapenia | |||||||
20–65 years old | Q2 v.s. Q1 | 1.37(0.99–1.89) | 0.06 | 1.42(1.02–1.99) | 0.04 | 1.37(0.98–1.93) | 0.07 |
Q3 v.s. Q1 | 1.69(1.24–2.31) | <0.001 | 1.74(1.26–2.40) | <0.001 | 1.67(1.20–2.32) | 0.003 | |
Q4 v.s. Q1 | 1.60(1.15–2.24) | 0.006 | 1.82(1.28–2.60) | <0.001 | 1.80(1.25–2.58) | <0.001 | |
>65 years old | Q2 v.s. Q1 | 1.62(1.16–2.27) | 0.005 | 1.64(1.16–2.33) | 0.006 | 1.57(1.10–2.23) | 0.013 |
Q3 v.s. Q1 | 1.86(1.31–2.62) | <0.001 | 1.76(1.23–2.51) | 0.002 | 1.71(1.19–2.46) | 0.004 | |
Q4 v.s. Q1 | 2.25(1.55–3.27) | <0.001 | 2.24(1.52–3.31) | <0.001 | 2.13(1.43–3.16) | <0.001 | |
Sarcopenia | |||||||
20–65 years old | Q2 v.s. Q1 | 1.13(0.96–1.33) | 0.151 | 1.10(0.88–1.38) | 0.400 | 1.11(0.88–1.33) | 0.376 |
Q3 v.s. Q1 | 1.37(1.17–1.61) | <0.001 | 1.13(0.90–1.41) | 0.285 | 1.13(0.90–1.41) | 0.297 | |
Q4 v.s. Q1 | 1.40(1.19–1.65) | <0.001 | 1.27(1.01–1.61) | 0.043 | 1.28(1.01–1.62) | 0.038 | |
>65 years old | Q2 v.s. Q1 | 1.53(1.16–2.02) | 0.003 | 1.11(0.75–1.65) | 0.595 | 1.14(0.77–1.70) | 0.513 |
Q3 v.s. Q1 | 1.99(1.50–2.64) | <0.001 | 1.20(0.81–1.78) | 0.371 | 1.24(0.83–1.85) | 0.297 | |
Q4 v.s. Q1 | 2.63(1.95–3.55) | <0.001 | 1.45(0.95–2.20) | 0.085 | 1.47(0.96–2.25) | 0.074 |
Model 1 = Unadjusted.
Model 2 = Model 1 + age, sex, race/ethnicity + BMI, serum fasting glucose, serum cholesterol, AST, serum HDL, serum calcium, serum creatinine.
Model 3 = Model 2 + history of congestive heart failure, coronary heart disease, angina/angina pectoris, heart attack, stroke, smoking.